Bright Minds Biosciences Statistics

Total Valuation

CSE:DRUG has a market cap or net worth of CAD 1.09 billion. The enterprise value is 997.73 million.

Market Cap	1.09B
Enterprise Value	997.73M

Important Dates

The last earnings date was Tuesday, February 10, 2026.

Earnings Date	Feb 10, 2026
Ex-Dividend Date	n/a

Share Statistics

CSE:DRUG has 9.79 million shares outstanding. The number of shares has increased by 48.78% in one year.

Current Share Class	9.79M
Shares Outstanding	9.79M
Shares Change (YoY)	+48.78%
Shares Change (QoQ)	+7.30%
Owned by Insiders (%)	16.49%
Owned by Institutions (%)	51.36%
Float	6.61M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
PB Ratio	12.17
P/TBV Ratio	12.17
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-50.28
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 57.37, with a Debt / Equity ratio of 0.00.

Current Ratio	57.37
Quick Ratio	56.59
Debt / Equity	0.00
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-442.41

Financial Efficiency

Return on equity (ROE) is -26.98% and return on invested capital (ROIC) is -15.92%.

Return on Equity (ROE)	-26.98%
Return on Assets (ROA)	-15.72%
Return on Invested Capital (ROIC)	-15.92%
Return on Capital Employed (ROCE)	-21.02%
Weighted Average Cost of Capital (WACC)	1.56%
Revenue Per Employee	n/a
Profits Per Employee	-763,241
Employee Count	26
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +132.18% in the last 52 weeks. The beta is -0.49, so CSE:DRUG's price volatility has been lower than the market average.

Beta (5Y)	-0.49
52-Week Price Change	+132.18%
50-Day Moving Average	115.33
200-Day Moving Average	73.67
Relative Strength Index (RSI)	47.86
Average Volume (20 Days)	537

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-18.77M
Pretax Income	-19.84M
Net Income	-19.84M
EBITDA	n/a
EBIT	-18.77M
Earnings Per Share (EPS)	-2.73

Full Income Statement

Balance Sheet

The company has 89.05 million in cash and 104,900 in debt, giving a net cash position of 88.94 million or 9.09 per share.

Cash & Cash Equivalents	89.05M
Total Debt	104,900
Net Cash	88.94M
Net Cash Per Share	9.09
Equity (Book Value)	89.28M
Book Value Per Share	11.47
Working Capital	89.21M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-13.01M
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

CSE:DRUG does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-48.78%
Shareholder Yield	-48.78%
Earnings Yield	-1.83%
FCF Yield	n/a

Stock Splits

The last stock split was on July 14, 2023. It was a reverse split with a ratio of 0.2.

Last Split Date	Jul 14, 2023
Split Type	Reverse
Split Ratio	0.2

Scores

Altman Z-Score	n/a
Piotroski F-Score	1